[Paraplegia syndrome following the use of co-trimoxazole].
D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects*; D003556:Cystitis / Q000188:drug therapy; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006801:Humans; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D010264:Paraplegia / Q000139:chemically induced* / Q000188:drug therapy; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000009:adverse effects*; D014295:Trimethoprim / Q000009:adverse effects*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D008776:Methylprednisolone Hemisuccinate; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; C009935:prednisolone acetate; D011239:Prednisolone; D014295:Trimethoprim; D013420:Sulfamethoxazole
Dwarslaesiesyndroom na gebruik van co-trimoxazol.